Sequence Modeling of Passive Sensing Data for Treatment Response Prediction in Major Depressive Disorder

被引:6
|
作者
Zou, Bochao [1 ]
Zhang, Xiaolong [2 ,3 ]
Xiao, Le [2 ,3 ]
Bai, Ran [4 ]
Li, Xin [1 ]
Liang, Hui [1 ]
Ma, Huimin [1 ]
Wang, Gang [2 ,3 ]
机构
[1] Univ Sci & Technol Beijing, Sch Comp & Commun Engn, Beijing 100083, Peoples R China
[2] Capital Med Univ, Beijing Anding Hosp, Natl Clin Res Ctr Mental Disorders, Beijing 100088, Peoples R China
[3] Capital Med Univ, Beijing Anding Hosp, Beijing Key Lab Mental Disorders, Beijing 100088, Peoples R China
[4] Natl Engn Lab Risk Percept & Prevent, Beijing 100141, Peoples R China
基金
中国国家自然科学基金;
关键词
Depression; Predictive models; Data models; Machine learning; Correlation; Task analysis; Hospitals; Major depressive disorder; treatment response prediction; digital phenotyping; sequence modeling; USAGE; RISK;
D O I
10.1109/TNSRE.2023.3260301
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Major depressive disorder (MDD) is a prevalent mental health condition and has become a pressing societal challenge. Early prediction of treatment response may aid in the rehabilitation engineering of depression, which is of great practical significance for the relief of suffering and burden of MDD. In this paper, we present a sequence modeling approach that uses data collected by passive sensing techniques to predict patients with an outcome of treatment responded defined by the reduction in clinical administrated scales. Hundreds of patients with MDD have been recruited from outpatient clinics at 4 psychiatric sites. Each has been delivered with a self-developed app to passively record their daily phone usage and physical data with minimal human action. An unavoidable dilemma in passive sensing is missing values. To overcome that, the proposed approach combined feature extraction and sequence modeling methods to fully utilize the pattern of missing values from longitudinal data. With no treatment constraints, it enables us to predict the treatment response of MDD 8-10 weeks before the completion of the treatment course, leaving time for preventative measures. Our work explored the feasibility of treatment response prediction using longitudinal passive sensing data and sparse ground truth, and also has the potential for preventing depression by forecasting treatment outcomes weeks in advance.
引用
收藏
页码:1786 / 1795
页数:10
相关论文
共 50 条
  • [41] Exposure-response Modeling From the CLARITY Trial of Pimavanserin for Adjunctive Treatment of Major Depressive Disorder
    Darwish, Mona
    Dirks, Bryan
    Passarell, Julie
    Jaworowicz, David
    Bihorel, Sebastien
    Howell, Becky
    Owen, Joel
    DeKarske, Daryl
    Stankovic, Srdjan
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2023, 12 (05): : 463 - 474
  • [42] Treatment adherence and response to psychopharmacological treatment in borderline personality disorder with and without major depressive disorder
    Batmaz, S.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S439 - S440
  • [43] The association of COMT genotype with buproprion treatment response in the treatment of major depressive disorder
    Fawver, Jay
    Flanagan, Mindy
    Smith, Thomas
    Drouin, Michelle
    Mirro, Michael
    BRAIN AND BEHAVIOR, 2020, 10 (07):
  • [44] Early Prediction of Fluoxetine Response for Han Chinese Inpatients With Major Depressive Disorder
    Lin, Ching-Hua
    Lane, Hsien-Yuan
    Chen, Cheng-Chung
    Juo, Suh-Hang Hank
    Yen, Cheng-Fang
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31 (02) : 187 - 193
  • [45] Multivariate prediction of response to fluoxetine and placebo in children and adolescents with major depressive disorder
    Kowatch, RA
    Carmody, TJ
    Emslie, GJ
    Rintelmann, JR
    Hughes, CW
    Rush, AJ
    PSYCHOPHARMACOLOGY BULLETIN, 1997, 33 (03) : 539 - 539
  • [46] Early prediction of clinical response in patients with major depressive disorder receiving fluoxetine
    Lin, C. H.
    Lin, K. S.
    Chen, M. C.
    Chou, L. S.
    Chen, C. C.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2008, 18 : S335 - S335
  • [47] Neural Correlates of Antidepressant Treatment Response in Adolescents with Major Depressive Disorder
    Cullen, Kathryn R.
    Klimes-Dougan, Bonnie
    Dung Pham Vu
    Schreiner, Melinda Westlund
    Mueller, Bryon A.
    Eberly, Lynn E.
    Camchong, Jazmin
    Westervelt, Ana
    Lim, Kelvin O.
    JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2016, 26 (08) : 705 - 712
  • [48] EPA and DHA as markers of nutraceutical treatment response in major depressive disorder
    van der Burg, Kiki P.
    Cribb, Lachlan
    Firth, Joseph
    Karmacoska, Diana
    Mischoulon, David
    Byrne, Gerard J.
    Bousman, Chad
    Stough, Con
    Murphy, Jenifer
    Oliver, Georgina
    Berk, Michael
    Ng, Chee H.
    Sarris, Jerome
    EUROPEAN JOURNAL OF NUTRITION, 2020, 59 (06) : 2439 - 2447
  • [49] Gene expression biomarkers of response to citalopram treatment in major depressive disorder
    Mamdani, F.
    Berlim, M. T.
    Beaulieu, M-M
    Labbe, A.
    Merette, C.
    Turecki, G.
    TRANSLATIONAL PSYCHIATRY, 2011, 1 : e13 - e13
  • [50] Response trajectories during escitalopram treatment of patients with major depressive disorder
    Nunez, John-Jose
    Liu, Yang S.
    Cao, Bo
    Frey, Benicio N.
    Ho, Keith
    Milev, Roumen
    Mueller, Daniel J.
    Rotzinger, Susan
    Soares, Claudio N.
    Taylor, Valerie H.
    Uher, Rudolf
    Kennedy, Sidney H.
    Lam, Raymond W.
    PSYCHIATRY RESEARCH, 2023, 327